Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
# Aster DM Healthcare: ESG Financial Risk Summary Aster DM Healthcare faces a critical **compliance exposure of ₹7–25 crore** under SEBI's BRSR Core Expansion mandate, with a maximum compliance risk score of 10.0/10 indicating near-certain regulatory breach likelihood. The company's **unknown EPR (Extended Producer Responsibility) applicability** creates secondary financial risk, particularly if medical waste management and pharmaceutical packaging fall under EPR schedules—potentially triggering liability for end-of-life product recovery costs estimated at 2–5% of relevant product revenue. Scope 1 & 2 emissions reporting gaps and unquantified water/energy intensity metrics suggest incomplete disclosure, exposing the company to SEBI enforcement action, trading suspensions, or delisting risk if top-tier classification applies. Immediate action is required to (1) clarify EPR applicability, (2) baseline Scope 1/2 emissions across ₹4,138.5 crore revenue base, and (3) complete BRSR P6 environmental disclosures to avoid regulatory penalties exceeding
Source: Aster DM Healthcare Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.